Efficacy and prognosis of HER2-Low and HER2-Zero in triple-negative breast cancer after neoadjuvant chemotherapy

Efficacy and prognosis of HER2-Low and HER2-Zero in triple-negative breast cancer after neoadjuvant chemotherapy

Clinicopathologic characteristics analysis between HER2-Low and HER2-Zero patients

A total of 638 TNBC patients were analyzed in the present study. Baseline demographics and clinical–pathological characteristics stratified by HER2 status were summarized in Table1. In the entire cohort, 342…

[ad_2]

Source link

More From Author

States across US are seeing seasonal increase in mosquitoes with West Nile virus

States across US are seeing seasonal increase in mosquitoes with West Nile virus

Windsor-Essex health unit issues warning after rabid bat found

Leave a Reply

Your email address will not be published. Required fields are marked *